Michael Linenberger - Concepedia

Author

Michael Linenberger

Also Known As

Kamani, Nayesh R., M L Linenberger, M Linenberger, M. L. Linenberger, M.L. Linenberger, Michael L Linenberger, Michael L. Linenberger, Michael Linenberger, Murthy, Hemant S., Shaw, Bronwen E.

118

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

University of Washington Fred Hutch Cancer Center Seattle Cancer Care Alliance National Marrow Donor Program Children's Hospital of Los Angeles

About

Michael Linenberger is an author at University of Washington specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.7K
2	Health Sciences	4	4	670
3	Cell Biology	4	4	319
4	Biostatistics	1	1	22
5	Blood Transplantation	1	1	12

Michael Linenberger

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue Joseph E. Schwartz, Jeffrey L. Winters, Anand Padmanabhan, Journal of Clinical Apheresis Evidence-based TherapyWriting CommitteePatient SafetyClinical TrialsDiagnosis	2013	593
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis Zbigniew M. Szczepiorkowski, Nicholas Bandarenko, Haewon C. Kim, Journal of Clinical Apheresis	2007	545
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis Zbigniew M. Szczepiorkowski, Jeffrey L. Winters, Nicholas Bandarenko, Journal of Clinical Apheresis Clinical DisordersRheumatologyHealth SciencesClinical InjuryClinical Epidemiology	2010	500
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin Michael Linenberger, Tom C. Hong, David Flowers, Blood	2001	198
Hematopoietic Cell Transplantation as Curative Therapy for Idiopathic Myelofibrosis, Advanced Polycythemia Vera, and Essential Thrombocythemia Daniella Kerbauy, Theodore A. Gooley, George E. Sale, Biology of Blood and Marrow Transplantation	2007	179
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation Bart L. Scott, Ted Gooley, Mohamed L. Sorror, Blood	2012	147
Multidrug resistance protein attenuates gemtuzumab ozogamicin–induced cytotoxicity in acute myeloid leukemia cells Roland B. Walter, Brian W. Raden, Tom C. Hong, Blood	2003	131
Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma Jennifer Rohn, Adam S. Lauring, Michael Linenberger, Journal of Virology Lymphoid NeoplasiaNotch2 ProteinMolecular VirologyImmunologyViral Pathogenesis	1996	115
Evidence for the maintenance of hematopoiesis in a large animal by the sequential activation of stem-cell clones. Janis L. Abkowitz, Michael Linenberger, Michael A. Newton, Proceedings of the National Academy of Sciences GeneticsStem Cell BiologyBone Marrow FailureLarge AnimalStem Cell Mobilization	1990	96
Lymphokines modulate the growth and survival of thymic tumor cells containing a novel feline leukemia virus/Notch2 variant Michael Linenberger, Jennifer Rohn, Deng Ta, Veterinary Immunology and Immunopathology Lymphoid NeoplasiaImmunologyThymic Tumor CellsAdult T-cell Leukemia-lymphomaImmunotherapy	1999	86

Page 1